P...Who would be making the deal? Professor Masters who was awarded the exclusive license hopefully with royalties paid to Alterity. I thought the good Doctor Masters necessarily needed to conduct additional studies with PBT2 that, with positive results, could result in regulatory approvals without the need for Phase 3 clinical trials? Maybe he has or has not done so. As you pointed out, it's been 3 years! I also vaguely recall that he has done some testing in the last 2-3 tears with a very promising Japanese biotech drug to treat antibiotic resistance to bacterial infections. Hopefully, I am wrong about this, but it might explain why there has been no update/news from Masters which is very concerning if not aggravating.
News: ATH Alterity Therapeutics Seeks Trading Halt, page-18
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(11.1%) |
Mkt cap ! $20.98M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.4¢ | $14.55K | 3.241M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 62 | 71906262 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 32338803 | 25 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| ATH (ASX) Chart |